A&G Pharmaceutical Receives 2009 Maryland Business Incubator Award
News Jun 22, 2009
A&G Pharmaceutical received the “Best Graduate Company” Award at the 2009 Maryland Incubator of the Year Awards on June 16, 2009.
The award was presented in recognition of the company’s diagnostic products in development based on a biological target, or biomarker, discovered by A&G researchers known as GP88/PGRN, which plays a critical role in helping the cancer to grow and proliferate.
A&G initiated operations in 2000 in the Emerging Technology Center incubator in Baltimore to develop and commercialize linked therapeutic-diagnostic products for personalized medicine based on its biomarker discoveries, with a focus on cancer.
The company, which now has 22 employees, has two diagnostic tests for breast cancer in clinical trials, a linked breast cancer therapeutic in development, and additional longer-term diagnostic products in development for lung cancer and prostate cancer.
“We are very pleased that the Maryland business community has bestowed the honor of Best Graduate Company on A&G,” said Ginette Serrero, PhD, Chief Executive Officer of A&G. “We could not accept this award without acknowledging Ann Lansinger, President of the Emerging Technology Centers, who provided the critical assistance at A&G’s inception that enabled us to incubate.
Lipid droplets have been found to play critical roles in the life cycles of certain proteins involved in gene expression. Now, a new study describes how lipid droplets regulate these proteins. The research has implications for understanding what helps embryos survive and could cause us to reconsider how we look at lipid-related diseases like obesity.READ MORE